Provided by Tiger Trade Technology Pte. Ltd.

Integra Lifesciences

13.44
+0.03000.22%
Post-market: 13.440.00000.00%16:38 EDT
Volume:1.23M
Turnover:16.55M
Market Cap:1.05B
PE:-144.33
High:13.86
Open:13.38
Low:13.23
Close:13.41
52wk High:20.49
52wk Low:8.70
Shares:77.89M
Float Shares:58.67M
Volume Ratio:0.70
T/O Rate:2.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0931
EPS(LYR):-6.7400
ROE:-0.70%
ROA:2.82%
PB:1.00
PE(LYR):-1.99

Loading ...

Argus Research Upgrades Integra LifeSciences to Buy From Hold, $25 Price Target

MT Newswires Live
·
Jun 18

Integra LifeSciences upgraded to Buy from Hold at Argus

TIPRANKS
·
Jun 18

Integra Lifesciences Holdings Corp : Argus Research Raises to Buy From Hold

THOMSON REUTERS
·
Jun 18

Integra LifeSciences to present at Truist Securities MedTech Conference

Reuters
·
Jun 15

Integra LifeSciences (IART) Is Up 8.1% After Q1 Beat And Outlook Update At Jefferies Conference

Simply Wall St.
·
Jun 09

NASDAQ New 52-Week Highs And Lows

Dow Jones
·
Jun 05

Integra LifeSciences CFO Lea Knight presents at Jefferies Global Healthcare Conference

Reuters
·
Jun 02

Integra Lifesciences Holdings Corp : Citigroup Raises to Neutral From Sell; Raises Target Price to $16 From $11

THOMSON REUTERS
·
May 29

Integra LifeSciences Raised to Neutral From Sell by Citigroup

Dow Jones
·
May 29

Citigroup Upgrades Integra LifeSciences to Neutral From Sell, Adjusts Price Target to $16 From $11

MT Newswires Live
·
May 28

Analysts Offer Insights on Healthcare Companies: Kairos Pharma, Ltd. (KAPA), Integra Lifesciences (IART) and Biogen (BIIB)

TIPRANKS
·
May 14

Integra LifeSciences shareholders approve equity plan amendment at annual meeting

Reuters
·
May 09

Integra LifeSciences CFO Lea Knight presents at BofA Securities health care conference

Reuters
·
May 08

Integra LifeSciences price target raised to $11 from $9 at Citi

TIPRANKS
·
May 07

Integra LifeSciences Is Maintained at Sell by Citigroup

Dow Jones
·
May 07

Integra Lifesciences (IART) Gets a Buy from Jefferies

TIPRANKS
·
May 07

Integra LifeSciences names Stuart Essig president and CEO in leadership transition

Reuters
·
May 06

Truist Adjusts Price Target on Integra LifeSciences to $14 From $12, Maintains Hold Rating

MT Newswires Live
·
May 06

Truist Financial Keeps Their Hold Rating on Integra Lifesciences (IART)

TIPRANKS
·
May 06

Integra Lifesciences Earnings Call Highlights Mixed Recovery

TIPRANKS
·
May 06